期刊文献+

碳氢酶烯类抗菌药物和替加环素在医院使用情况分析 被引量:5

Analysis report on clinical utilization of carbapenem and tigecycline in the hospital
下载PDF
导出
摘要 目的为临床合理使用碳氢酶烯类抗菌药物和替加环素提供参考依据。方法回顾性统计分析安徽省第二人民医院2018年1—6月碳氢酶烯类抗菌药物和替加环素的使用情况。结果碳氢酶烯类和替加环素共计使用647例,其中使用例数较多的为美罗培南和比阿培南,分别为440例和176例;亚胺培南和替加环素占比较少,分别为24例和7例。用药合理率为68.16%,会诊率为49.61%,送检率达87.17%,非紧急情况下使用率为56.88%。结论该院住院病人的碳氢酶烯类抗菌药物和替加环素的应用较为合理,但仍存在少许不完善之处,亦需进一步结合国家卫生行政部门的相关政策法规加大管理力度,强化合理使用,保障安全用药。 Objective Providing a reference for the rational utilization of carbapenem and tigecycline in clinic.Methods A retro spective statistical analysis was conducted on the utilization of carbapenem and tigecycline in our hospital from January to June 2018.Results A total of 647 cases of utilization of carbapenem and tigecycline,among which meropenem and biapenem were most,as 440 cases and 176 cases respectively.Imipenem and tigecycline accounted for less,as 24 cases and 7 cases respectively.The rate of rational use of medication,the consultation,bacterial inspection was 68.16%,49.61%and 87.17%respectively.The rate of non emergency use accounting for 56.88%.Conclusion The utilization of carbapenem and tigecycline is relatively reasonable in our hospital.However,there are still some flaws.It is necessary to further strengthen the management,boost the rational utilization of these antibacterial drugs with relevant policies and regulations of the government departments to ensure the safety of medication.
作者 刘建军 吕敏 蒋磊 刘俊 王昊 陈飞虎 LIU Jianjun;LYU Min;JIANG Lei;LIU Jun;WANG Hao;CHEN Feihu(Department of Pharmacy,Anhui No.2 Provincial People’s Hospital,Hefei,Anhui 230041,China;Department of Pharmacy,The Second Hospital of Anhui Medical University,Hefei,Anhui 230601,China;Clinical Laboratory Department,Anhui Provincial Hospital,The First Affiliated Hospital of University of Science and Technology of China,Hefei,Anhui 230001,China;School of Pharmacy,Anhui Medical University,Hefei,Anhui 230032,China)
出处 《安徽医药》 CAS 2020年第5期1027-1031,共5页 Anhui Medical and Pharmaceutical Journal
基金 国家自然科学基金(81502599)。
关键词 药物利用评审 碳氢酶烯类 替加环素 处方不当 抗药性 细菌 风险防控 合理用药 Drug utilization review Carbapenem Tigecycline Inappropriate prescribing Drug resistance bacterial Risk prevention and control Rational utilization of drugs
  • 相关文献

参考文献14

二级参考文献136

  • 1王艳丽,黄茂,梅亚宁,殷凯生.鲍曼不动杆菌对喹诺酮类药物的耐药机制研究[J].中国感染与化疗杂志,2008,8(4):266-270. 被引量:24
  • 2刘又宁,佘丹阳.我国下呼吸道感染致病原的构成、耐药特点及治疗策略[J].中国临床医生杂志,2005,33(3):2-6. 被引量:27
  • 3杨彤,何艳玲.100例患儿围手术期预防感染用抗菌药调查[J].药物流行病学杂志,2007,16(5):304-306. 被引量:8
  • 4Clinical and Laboratory Standards Institute CCl.Sl). Performance standards for Antimicrobial susceptibility testing[S]. 2013, Ml00-23.
  • 5Towner KJ. Acinetobacter: an old friend, but a new enemy [J]. J Hosp Infect, 2009, 73(4): 355-363.
  • 6Peleg A Y, Seifert H, Paterson DL. Acinetobacter baumannii : emergence of a successful pathogen [J]. Clin Microbiol Rev, 2008, 21(3): 538-582.
  • 7Robledo IE, Aquino EE,Sante MI,et al. Detection of KPC in Acinetobacter spp. In Puerto Rico [J]. Antimicrob Agents Chomother,2010,54(3): 1354-1357.
  • 8Naas T, Namdari F, Reglier-Poupet H, et al. Panresistant extended-spectrum f3-lactamase SHV-5-producing Acinetobacter baumannii from New York City [J]. J Antimicrob Chemother , 2007,60(5) :1174-1176.
  • 9Peymani A, Nahaei MR,Farajnia Sv er al. High prevalence of metallo-beta-Iactamase-producing Acinetobacter baumannii in a teaching hospital in Tabriz , Iran [J]. Ipn J Infect Dis, 2011,64(1) :69-71.
  • 10国家卫生部.抗菌药物临床应用管理办法[s].中华人民共和国卫生部令第84号.2012-04-24.

共引文献863

同被引文献45

引证文献5

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部